A phase II trial of capecitabine and vinorelbine as first-line treatment in patients with metastatic breast cancer (BC)

被引：0
|
作者：
Palumbo, Raffaella [1 ]
Bernardo, Antonio [1 ]
Strada, Maria Rosa [1 ]
Poggi, Guido [1 ]
Delmonte, Angelo [1 ]
Teragni, Cristina [1 ]
Frascaroli, Mara [1 ]
Bernardo, Giovanni [1 ]
机构：
[1] Fdn Maugeri, Pavia, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [1] Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
    Ghosn, M
    Kattan, J
    Farhat, F
    Younes, F
    Gasmi, J
    ANTICANCER RESEARCH, 2006, 26 (3B) : 2451 - 2456
  • [2] Activity and safety of vinorelbine and capecitabine as first-line treatment in patients with metastatic breast cancer - a phase II trial
    Palumbo, R.
    Bernardo, A.
    Strada, M.
    Teragni, C.
    Poggi, G.
    Frascaroli, M.
    Amatu, A.
    Palumbo, I.
    Bernardo, G.
    EJC SUPPLEMENTS, 2008, 6 (07): : 177 - 177
  • [3] Phase II study of vinorelbine and capecitabine as first-line treatment for metastatic breast cancer.
    El-Sadda, Wael
    Halim, Inas Ibraheim Abdel
    Aziz, Mohamed Abdel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Capecitabine and vinorelbine as first-line treatment in elderly patients (≥65 years) with metastatic breast cancer -: A phase II trial (SAKK 25/99)
    Hess, D.
    Koeberle, D.
    Thuerlimann, B.
    Pagani, O.
    Schoenenberger, A.
    Mattmann, S.
    Rochlitz, C.
    Rauch, D.
    Schuller, J. C.
    Ballabeni, P.
    Ribi, K.
    ONCOLOGY, 2007, 73 (3-4) : 228 - 237
  • [5] Vinorelbine and capecitabine combination as first-line treatment in patients with metastatic breast cancer: Final results of a multicentric trial in Egypt
    Elghazaly, H.
    Tawfik, H.
    Mahrous, M.
    Meshref, M. M.
    Sakr, A.
    Haddad, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Navcap (vinorelbine and capecitabine) versus navcap followed by weekly docetaxel as first-line treatment in metastatic breast cancer patients: A randomized multicenter phase II trial
    Ghosn, M.
    Farhat, F. S.
    Kattan, J. G.
    Hanna, C.
    Younes, F.
    Haddad, N.
    Aftimos, P.
    Nasr, F.
    Moukadem, W.
    Chahine, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] A phase II trial of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer
    Meshref, M. M.
    Samir, S.
    Saad, E.
    Gouda, Y.
    Elmesidy, S.
    Koheil, H.
    Elzawahri, H.
    Kandil, A.
    Abdelhamid, T.
    Zaki, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Vinorelbine, epirubicin and fluorouracil as first-line therapy in metastatic breast cancer - A phase II trial
    Elomaa, I
    Joensuu, H
    Blomqvist, C
    ACTA ONCOLOGICA, 2003, 42 (04) : 309 - 314
  • [9] Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer
    Blum, Joanne L.
    Dees, E. Claire
    Chacko, Aparna
    Doane, Lisa
    Ethirajan, Sukumar
    Hopkins, Judith
    McMahon, Richard
    Merten, Suzan
    Negron, Angel
    Neubauer, Marcus
    Ilegbodu, Des
    Boehm, Kristi A.
    Asmar, Lina
    O'Shaughnessy, Joyce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4384 - 4390
  • [10] Phase II Multicenter Trial of Albumin-Bound Paclitaxel and Capecitabine in First-Line Treatment of Patients With Metastatic Breast Cancer
    Schwartzberg, Lee S.
    Arena, Francis P.
    Mintzer, David M.
    Epperson, Amanda L.
    Walker, Mark S.
    CLINICAL BREAST CANCER, 2012, 12 (02) : 87 - 93
12345